XML 22 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2016
Dec. 31, 2015
Current Assets    
Cash and cash equivalents (variable interest entity restricted - 2016: $18; 2015: $7) $ 716 $ 967
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2016: $6; 2015: $6; variable interest entity restricted - 2016: $5; 2015: $6) 830 706
Non-trade receivables, net 212 285
Inventories 667 682
Deferred income taxes 0 68
Marketable securities, at fair value 31 30
Other assets 47 49
Total current assets 2,503 2,787
Investments in affiliates 870 838
Property, plant and equipment (net of accumulated depreciation - 2016: $2,132; 2015: $2,039; variable interest entity restricted - 2016: $763; 2015: $772) 3,640 3,609
Deferred income taxes 236 222
Other assets (variable interest entity restricted - 2016: $10; 2015: $13) 296 300
Goodwill 722 705
Intangible assets (net of accumulated amortization - 2016: $546; 2015: $528; variable interest entity restricted - 2016: $27; 2015: $27) 125 125
Total assets 8,392 8,586
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 116 513
Trade payables - third party and affiliates 574 587
Other liabilities 280 330
Deferred income taxes 0 30
Income taxes payable 125 90
Total current liabilities 1,095 1,550
Long-term debt, net of unamortized deferred financing costs 2,487 2,468
Deferred income taxes 116 136
Uncertain tax positions 176 167
Benefit obligations 1,176 1,189
Other liabilities $ 244 $ 247
Commitments and Contingencies
Stockholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2016 and 2015: 0 issued and outstanding) $ 0 $ 0
Treasury stock, at cost (2016 and 2015: 19,916,490 shares) (1,031) (1,031)
Additional paid-in capital 125 136
Retained earnings 3,834 3,621
Accumulated other comprehensive income (loss), net (283) (348)
Total Celanese Corporation stockholders' equity 2,645 2,378
Noncontrolling interests 453 451
Total equity 3,098 2,829
Total liabilities and equity 8,392 8,586
Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2016: 167,355,679 issued and 147,439,189 outstanding; 2015: 166,698,787 issued and 146,782,297 outstanding)    
Stockholders' Equity    
Common stock 0 0
Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2016 and 2015: 0 issued and outstanding)    
Stockholders' Equity    
Common stock $ 0 $ 0